Impact of Protein Intake in Older Adults with Sarcopenia and Obesity: A Gut Microbiota Perspective
Open accessThe DOI matches its Crossref record; 252 of the 252 references it cites were found in a registry or an index; 41 of the 115 sources its claims cite were checked for support.
Abstract
The continuous population increase of older adults with metabolic diseases may contribute to increased prevalence of sarcopenia and obesity and requires advocacy of optimal nutrition treatments to combat their deleterious outcomes. Sarcopenic obesity, characterized by age-induced skeletal-muscle atrophy and increased adiposity, may accelerate functional decline and increase the risk of disability and mortality. In this review, we explore the influence of dietary protein on the gut microbiome and its impact on sarcopenia and obesity. Given the associations between red meat proteins and altered gut microbiota, a combination of plant and animal-based proteins are deemed favorable for gut microbiota eubiosis and muscle-protein synthesis. Additionally, high-protein diets with elevated essential amino-acid concentrations, alongside increased dietary fiber intake, may promote gut microbiota eubiosis, given the metabolic effects derived from short-chain fatty-acid and branched-chain fatty-acid production. In conclusion, a greater abundance of specific gut bacteria associated with increased satiation, protein synthesis, and overall metabolic health may be driven by protein and fiber consumption. This could counteract the development of sarcopenia and obesity and, therefore, represent a novel approach for dietary recommendations based on the gut microbiota profile. However, more human trials utilizing advanced metabolomic techniques to investigate the microbiome and its relationship with macronutrient intake, especially protein, are warranted.
Overview
CoChat Summary
TL;DR
This narrative review argues that dietary protein amount and source, together with fiber, interact with the gut microbiota to influence sarcopenia and obesity in older adults, with combined plant and animal proteins plus high-protein/fiber diets potentially promoting eubiosis and muscle-protein synthesis. It concludes that more long-term human trials using advanced metabolomic techniques are needed before personalized microbiome-based protein recommendations can be made.
Key findings
- Sarcopenic obesity reflects age-related muscle loss plus increased adiposity; gut dysbiosis may contribute through inflammation, elevated LPS/TLR4 signaling, insulin resistance, and gut–muscle axis effects, while current dietary recommendations involve high-protein, hypocaloric diets.
- Protein source is linked to distinct microbiota: plant proteins are associated with greater *Bifidobacterium*, *Roseburia*, *Ruminococcus bromii*, and *Lactobacillus*, whereas animal proteins are associated with *Bacteroides*, *Alistipes*, *Bilophila*, and *Clostridium perfringens*; red meat is linked to TMAO, *Bacteroides*/*Fusobacterium*, and lower *Lactobacillus*/*Roseburia*.
- High-protein diets increase undigested protein reaching the colon—approximately 10% of proteins may pass the small intestine incompletely digested—producing metabolites including SCFAs, BCFAs, ammonia, and hydrogen sulfide; BCFA production from BCAA deamination may contribute approximately 5% of total SCFA production, while fiber fermentation yields acetate, propionate, and butyrate in an approximate 60:20:20 ratio.
- The paper suggests the RDA of 0.8 g/kg/day protein may be insufficient for older adults and cites leucine targets of around 3–4 g per meal, equating to 25–30 g high-quality protein and 1.0–1.6 g/kg/day across 3–4 meals; fiber targets cited include 30 g/day in the UK and 28 g/day for women and 38 g/day for men in Australia.
Methods
- Narrative review; no systematic review protocol, search strategy, or meta-analysis is described.
- Synthesizes human, animal, and in vitro evidence on dietary protein, amino acids, fiber, gut microbiota composition and metabolites, and sarcopenia/obesity outcomes, with Tables 1 and 2 summarizing protein-source and high-protein/low-carbohydrate diet findings.
- Main analysis is qualitative narrative synthesis linking microbial taxa and metabolites to metabolic and muscle outcomes; no new primary data are reported.
Limitations
- The paper states there is no causal link in humans, a lack of long-term experimental human trials on high-protein diets and the gut microbiome, most studies performed in mice, no universal consensus definition for sarcopenia/sarcopenic obesity, and a need for more human trials in sarcopenic obese groups.
- The paper notes plant-protein findings should be treated cautiously due to lack of experimental human studies, an athlete study is confounded by training and body composition, and it remains unclear whether altered microbial diversity is caused by aging or responsible for aging consequences.
- Evident from the text: as a narrative review, it does not systematically appraise study quality or risk of bias, and many cited findings come from animal, in vitro, or small human studies, limiting generalizability.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
18 Valid · 0 Not valid · 31 Not checked · 9 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In addition, considering the skeletal muscle anabolic effects of dietary protein, induction of increased protein intakes above the recommended dietary allowance (RDA) 0.8 g/kg/day is considered a valuable tool to counteract the gradual muscle loss and increased appetite for food [24]—a main characteristic of sarcopenic obesity.”
§ Impact of Protein Intake in Older Adults with Sarcopenia and Obesity: A Gut Microbiota Perspective > 1. Introduction
What the sources say
- Partly supportedcites [24] Muscariello E. Nasti G. Siervo M. Di Maro M. Lapi D. D’Addio G. Colantuoni A. Dietary protein intake in sarcopenic obese older women Clin. Interv. Aging 2016 11 133 140 10.2147/CIA.S96017 26917955 PMC4751896 sourceExperimental — accuracy not yet measured
Our copy supports the muscle-loss half: the Discussion states 'Protein intake of 0.8 g/kg DBW/day did not appear to preserve MM in sarcopenic women, while 1.2 g/kg DBW/day protein intake was effective in preserving MM', and the Abstract concludes 'adequate protein intake could contribute to the prevention of lean-mass loss associated with weight reduction in obese older people' (Abstract; Discussion). The Introduction also endorses intakes above the 0.8 g/kg/day RDA (citing Campbell et al. 1-1.25 g/kg/day and a proposed 1.4 g/kg/day). However, the claim additionally attributes to this source that increased appetite for food is countered and is 'a main characteristic of sarcopenic obesity'; no passage in our copy mentions appetite, hunger or energy-intake dysregulation (searched: appetite, food intake/sarcopenic obesity) — the paper describes sarcopenic obesity as characterized by reduced physical strength and increased disease risk (Introduction). Note also the source's evidence is bounded to hypocaloric weight-loss management over 3 months in sarcopenic obese women, not general age-related gradual muscle loss. (LLM, conf=0.78)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Multiple human and animal studies have linked increased branched-chain amino acids (BCAAs) with insulin resistance and type 2 diabetes in obese groups [150,151,152,153].”
§ Impact of Protein Intake in Older Adults with Sarcopenia and Obesity: A Gut Microbiota Perspective > 4. Sarcopenic Obesity: A Case for Protein and Gut Microbiota > 4.1. Dietary Protein and Gut Microbiota
What the sources say
- Partly supportedcites [150] Wang T.J. Larson M.G. Vasan R.S. Cheng S. Rhee E.P. McCabe E. Lewis G.D. Fox C.S. Jacques P.F. Fernandez C. Metabolite profiles and the risk of developing diabetes Nat. Med. 2011 17 448 453 10.1038/nm.2307 21423183 PMC3126616 sourceExperimental — accuracy not yet measured
The Discussion reports human and animal evidence linking branched-chain amino acids to insulin resistance, including a study of obese and non-obese people. The Results also link elevated amino acids to future diabetes. But this paper’s diabetes cohorts were not described as exclusively obese groups, so that population qualifier is not established for the diabetes finding. (LLM, conf=0.82)
- Partly supportedcites [151] Ridaura V.K. Faith J.J. Rey F.E. Cheng J. Duncan A.E. Kau A.L. Griffin N.W. Lombard V. Henrissat B. Bain J.R. Gut microbiota from twins discordant for obesity modulate metabolism in mice Science 2013 341 1241214 10.1126/science.1241214 24009397 PMC3829625 sourceExperimental — accuracy not yet measured
In “Functional differences between transplanted microbial communities” (page not provided), the paper reports higher BCAAs in mice receiving microbiota from obese twins and says these elevations resemble those reported in obese, insulin-resistant humans. It does not establish a BCAA link to type 2 diabetes, and its “Diet-specific effects” section says further study is needed to determine whether the observed mouse phenotype develops into insulin resistance. (LLM, conf=0.86)
- Supportedcites [152] Zhao X. Han Q. Liu Y. Sun C. Gang X. Wang G. The relationship between branched-chain amino acid related metabolomic signature and insulin resistance: A systematic review J. Diabetes Res. 2016 2016 2794591 10.1155/2016/2794591 27642608 PMC5014958 source
The Introduction reports increased circulating BCAA-related metabolites in insulin-resistant rats and humans and links BCAA concentrations to later type 2 diabetes. Results §3.2 reports elevated BCAAs associated with insulin resistance in obese adults, while Results §3.3 summarizes prospective studies linking elevated BCAAs to diabetes risk. The review supports the citing sentence as a broad summary, not as a claim that every study examined obese animals and humans for both outcomes. (LLM, conf=0.88)
- Partly supportedcites [153] Bloomgarden Z. Diabetes and branched-chain amino acids: What is the link? J. Diabetes 2018 10 350 352 10.1111/1753-0407.12645 29369529 sourceExperimental — accuracy not yet measured
The Abstract (page unavailable) reports elevated BCAAs in obese people with features of insulin resistance, higher BCAA levels in people with or before type 2 diabetes, and improved insulin sensitivity after dietary BCAA reduction in an animal model. It does not say the animal model or the human diabetes cohorts were obese, so the claim's 'in obese groups' qualifier is not established for all the studies it describes. (LLM, conf=0.82)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In accordance, undigested amino acids by the colonic epithelium may be used by the host through BCFA and SCFA activity to regulate protein homeostasis and energy production by muscle cells [141,142,155,156].”
§ Impact of Protein Intake in Older Adults with Sarcopenia and Obesity: A Gut Microbiota Perspective > 4. Sarcopenic Obesity: A Case for Protein and Gut Microbiota > 4.1. Dietary Protein and Gut Microbiota
What the sources say
- Not checked yetcites [141] Davila A.M. Blachier F. Gotteland M. Andriamihaja M. Benetti P.H. Sanz Y. Tome D. Intestinal luminal nitrogen metabolism: Role of the gut microbiota and consequences for the host Pharmacol. Res. 2013 68 95 107 10.1016/j.phrs.2012.11.005 23183532 source
- Not checked yetcites [142] Metges C.C. Contribution of microbial amino acids to amino acid homeostasis of the host J. Nutr. 2000 130 1857S 1864S 10.1093/jn/130.7.1857S 10867063 source
- Partly supportedcites [155] Bergen W.G. Wu G. Intestinal nitrogen recycling and utilization in health and disease J. Nutr. 2009 139 821 825 10.3945/jn.109.104497 19282369 sourceExperimental — accuracy not yet measured
In “Endogenous sources of nitrogen and recycling in the intestine” (page not available), the paper says colonic microbes metabolize amino acids to produce short-chain fatty acids. It does not say that these products regulate protein homeostasis or energy production in muscle cells, and it describes colonic microbes—not the colonic epithelium—as principally responsible for protein breakdown in the colon. (LLM, conf=0.86)
- Not checked yetcites [156] Mu C. Yang Y. Yu K. Yu M. Zhang C. Su Y. Zhu W. Alteration of metabolomic markers of amino-acid metabolism in piglets with in-feed antibiotics Amino Acids 2017 49 771 781 10.1007/s00726-017-2379-4 28101652 source
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“It is suggested that protein sources and amino-acid balance may influence gut microbial diversity. For instance, plant proteins are associated with greater Bifidobacterium, Roseburia, Ruminococcus bromii, Lactobacillus, and Roseburia content [161], as opposed to Bacteroides, Alistipes, Bilophila, and Clostridium perfrigens, found primarily in animal proteins [64,162].”
§ Impact of Protein Intake in Older Adults with Sarcopenia and Obesity: A Gut Microbiota Perspective > 4. Sarcopenic Obesity: A Case for Protein and Gut Microbiota > 4.2. Protein Sources, Amino Acids, and Gut Microbiota Species
What the sources say
- Partly supportedcites [161] Tomova A. Bukovsky I. Rembert E. Yonas W. Alwarith J. Barnard N.D. Kahleova H. The effects of vegetarian and vegan diets on gut microbiota Front. Nutr. 2019 6 47 10.3389/fnut.2019.00047 31058160 PMC6478664 sourceExperimental — accuracy not yet measured
The Proteins section says protein consumption correlates with microbial diversity and that animal and plant proteins affect gut microbiota differently. It does not discuss amino-acid balance as an influence on diversity; the protein-source examples concern the abundance of particular bacteria. (LLM, conf=0.86)
- Partly supportedcites [64] David L.A. Maurice C.F. Carmody R.N. Gootenberg D.B. Button J.E. Wolfe B.E. Ling A.V. Devlin A.S. Varma Y. Fischbach M.A. Diet rapidly and reproducibly alters the human gut microbiome Nature 2014 505 559 563 10.1038/nature12820 24336217 PMC3957428 sourceExperimental — accuracy not yet measured
The paper reports that an animal-based diet increased Alistipes, Bilophila, and Bacteroides, supporting that part of the cited example (Abstract; page not provided). It does not identify Clostridium perfringens among those taxa or test amino-acid balance separately. It found a change in between-sample microbial diversity on the animal-based diet, but no significant change in within-sample diversity. (LLM, conf=0.86)
- Not checked yetcites [162] Cotillard A. Kennedy S.P. Kong L.C. Prifti E. Pons N. Le Chatelier E. Almeida M. Quinquis B. Levenez F. Galleron N. Dietary intervention impact on gut microbial gene richness Nature 2013 500 585 588 10.1038/nature12480 23985875 source
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Moreover, the variety of amino acids from different protein types available to the intestinal bacteria may regulate whole-body amino acid metabolism and protein utilization [207].”
§ Impact of Protein Intake in Older Adults with Sarcopenia and Obesity: A Gut Microbiota Perspective > 4. Sarcopenic Obesity: A Case for Protein and Gut Microbiota > 4.2. Protein Sources, Amino Acids, and Gut Microbiota Species
What the sources say
- Partly supportedcites [207] Puiman P. Stoll B. Molbak L. de Bruijn A. Schierbeek H. Boye M. Boehm G. Renes I. van Goudoever J. Burrin D. Modulation of the gut microbiota with antibiotic treatment suppresses whole body urea production in neonatal pigs Am. J. Physiol. Gastrointest. Liver Physiol. 2013 304 G300 G310 10.1152/ajpgi.00229.2011 23139222 PMC3566514 sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) says intestinal bacteria can catabolize and synthesize amino acids, affecting their availability to the host. The paper also reports changes in whole-body threonine turnover and protein synthesis after microbiota modulation, but it does not examine whether amino acids from different protein types regulate those outcomes. It found no change in net whole-body threonine balance. (LLM, conf=0.86)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
24 more claims · 1 with their cited sources checked
Create a free account to see all 58 claims and to verify the 74 references still open.
- Probably not a substantial claim. 6
- It may state two separate claims as one. 26
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Importantly, therapeutic weight loss targeting excess fat inevitably leads to loss of variable amounts of skeletal muscle mass, which may be more pronounced in individuals with predisposing catabolic conditions (chronic diseases, ageing), following bariatric surgery (particularly in the absence of nutritional supervision and follow-up) or in the presence of long-lasting inappropriate or unbalanced”
From Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement (2022) · cites this paper as [7]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Impact of Protein Intake in Older Adults with Sarcopenia and Obesity: A Gut Microbiota Perspective > 4. Sarcopenic Obesity: A Case for Protein and Gut Microbiota > 4.2. Protein Sources, Amino Acids, and Gut Microbiota Species
“Furthermore, delayed age-associated microbiota changes in mice have been observed by BCAA consumption, displaying a greater abundance of Bifidobacterium and Akkermansia [210]”
§ Impact of Protein Intake in Older Adults with Sarcopenia and Obesity: A Gut Microbiota Perspective > References
“210. Depommier C. Everard A. Druart C. Plovier H. Van Hul M. Vieira-Silva S. Falony G. Raes J. Maiter D. Delzenne N.M. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: A proof-of-concept exploratory study Nat. Med. 2019 25 1096 1103”
Citations
Cites
1 retracted
Han, G., Lee, J.-Y., Jin, G.-D., Park, J., Choi, Y. H., Chae, B. J., Kim, E. B., & Choi, Y. (2016) · Veterinary Microbiology · doi:10.1016/j.vetmic.2016.10.020 · Cited by 21
RetractedSarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afy169 · Cited by 13,818 · cited 1×
“Although several definitions of sarcopenia are currently available, including the recently revised European Working Group on Sarcopenia in Older People (EWGSOP) definition, the lack of a universal consensus on definition limits comparison between studies and amongst various population groups [11].”
BackgroundAn obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444 · cited 1×
“Microbial alterations are associated with multiple diseases, such as cancer, sarcopenia, obesity, and cardiovascular diseases [48,66,67].”
BackgroundNg, M., Fleming, T., Robinson, M., Thomson, B., Graetz, N., Margono, C., Mullany, E. C., Biryukov, S., Abbafati, C., Abera, S. F., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60460-8 · Cited by 11,952
Diet rapidly and reproducibly alters the human gut microbiome
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., et al. (2014) · Nature · doi:10.1038/nature12820 · Cited by 10,100 · cited 3×
“Multiple studies have linked dietary patterns with changes in the gut ecosystem, displaying a distinct role of macronutrients and their impact on the gut microbiota environment [64,86].”
BackgroundRevised Estimates for the Number of Human and Bacteria Cells in the Body
Sender, R., Fuchs, S., & Milo, R. (2016) · PLOS Biology · doi:10.1371/journal.pbio.1002533 · Cited by 5,425 · cited 1×
“A recent study showed that the ratio of human to bacterial cells is almost 1:1 [47].”
Backgroundden Besten, G., van Eunen, K., Groen, A. K., Venema, K., Reijngoud, D.-J., & Bakker, B. M. (2013) · Journal of Lipid Research · doi:10.1194/jlr.r036012 · Cited by 5,048 · cited 1×
“, dietary fiber) consumption [213] during colonic bacterial fermentation [214].”
BackgroundRichness of human gut microbiome correlates with metabolic markers
Le Chatelier, E., Nielsen, T., Qin, J., Prifti, E., Hildebrand, F., Falony, G., Almeida, M., Arumugam, M., Batto, J.-M., Kennedy, S., et al. (2013) · Nature · doi:10.1038/nature12506 · Cited by 4,662 · cited 1×
“Higher microbial diversity from increased Bifidobacterium and Lactobacillus may promote more efficient nutrient absorption and amino-acid synthesis, whereas low microbial diversity is associated with excess nutrient uptake and storage and increased Firmicutes to Bacteroidetes ratio [91,92].”
BackgroundCross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity
Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J. P., Druart, C., Bindels, L. B., Guiot, Y., Derrien, M., Muccioli, G. G., Delzenne, N. M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219451110 · Cited by 4,511 · cited 1×
“Furthermore, delayed age-associated microbiota changes in mice have been observed by BCAA consumption, displaying a greater abundance of Bifidobacterium and Akkermansia [210], which improve glucose homeostasis and insulin sensitivity [182,211,212].”
BackgroundFunctional interactions between the gut microbiota and host metabolism
Tremaroli, V., & Bäckhed, F. (2012) · Nature · doi:10.1038/nature11552 · Cited by 4,387 · cited 1×
“A developing field in the role of optimal dietary patterns for sarcopenia and obesity management is characterizing the ideal eubiosis of the gut microbiota ecosystem [42,43].”
Background
Cited by
Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement
Donini, L. M., Busetto, L., Bischoff, S. C., Cederholm, T., Ballesteros-Pomar, M. D., Batsis, J. A., Bauer, J. M., Boirie, Y., Cruz-Jentoft, A. J., Dicker, D., et al. (2022) · Obesity Facts · doi:10.1159/000521241 · Cited by 1,019
Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement
Donini, L. M., Busetto, L., Bischoff, S. C., Cederholm, T., Ballesteros-Pomar, M. D., Batsis, J. A., Bauer, J. M., Boirie, Y., Cruz-Jentoft, A. J., Dicker, D., et al. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2021.11.014 · Cited by 566
Strasser, B., Wolters, M., Weyh, C., Krüger, K., & Ticinesi, A. (2021) · Nutrients · doi:10.3390/nu13062045 · Cited by 176
Ticinesi, A., Mancabelli, L., Tagliaferri, S., Nouvenne, A., Milani, C., Rio, D. D., Lauretani, F., Maggio, M. G., Ventura, M., & Meschi, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21238946 · Cited by 163
Sarcopenic Obesity: An Emerging Public Health Problem
Ji, T., Li, Y., & Ma, L. (2022) · Aging and disease · doi:10.14336/ad.2021.1006 · Cited by 124
Metadata
- Authors
- Prokopidis, K., Cervo, M. M., Gandham, A., & Scott, D.
- Affiliations
- Imperial College London (GB)
- Monash Health (AU)
- Deakin University (AU)
- Corresponding author
- Prokopidis, Konstantinos
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2020-07-30
- Volume
- 12
- Issue
- 8
- Pages
- 2285
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC7468805
- OpenAlex
- W3045515341
- Semantic Scholar
- 7d4f654e3b3a71bd5b801a33d7a94b9b5d1f27cf
- Cited by
- 99
- References
- 249
- Citations by year
- 2026: 16 · 2025: 19 · 2024: 19 · 2023: 18 · 2022: 12 · 2021: 13 · 2020: 2
- FWCI
- 1.08
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Monash University Research Portal (Monash University) (submittedVersion, cc-by)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Nursing › Nutrition and Dietetics › Muscle metabolism and nutrition
- Keywords
- sarcopenic obesity, sarcopenia, obesity, dietary protein, gut microbiota, older adults, red meat, plant proteins, muscle protein synthesis, short-chain fatty acids, branched-chain fatty acids, dietary fiber, essential amino acids, satiety, functional decline
- MeSH terms
- Gastrointestinal Microbiome, Aged, Aged, 80 and over, Dietary Fiber, Dietary Proteins, Eating, Female, Humans, Male, Nutritional Status, Obesity, Sarcopenia, Elder Nutritional Physiological Phenomena
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Impact of Protein Intake in Older Adults with Sarcopenia and Obesity: A Gut Microbiota Perspective. https://app.cochat.ai/papers/10.3390/nu12082285
- The paper
- Prokopidis, K., Cervo, M. M., Gandham, A., & Scott, D. (2020). Impact of Protein Intake in Older Adults with Sarcopenia and Obesity: A Gut Microbiota Perspective. Nutrients. https://doi.org/10.3390/nu12082285
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
![Figure 1 Bacterial types in the microbiome. Firmicutes and Bacteroidetes in the highlighted box represent approximately 90% of the total gut microbiota. Note. Adapted from [51].](https://figures.cochat.ai/paper-figures/17449968afb449c09e1cbb659475a81c/impact-of-protein-intake-in-older-adults-with-sarcopenia-and-obesity-a-gut-figure-1.jpg)